In this study, we sought to determine whether an uncontrolled circadian rhythm due to abnormal expression of BMAL1, a key regulator of the circadian clock, could influence on the tumor-promoting activities of glioblastoma cells. This evidence concerns the gene CLOCK and neoplasm.